Home › Trial NCT00536107
Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Trial IDNCT00536107
- StatusTerminated
- PhasePhase 4
- Study typeInterventional
- SponsorAstraZeneca
- Enrollment14
- Start date2007-10
- ConditionsCarcinoma, Non-Small-Cell Lung
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.